Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W K Seto

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Alimentary Pharmacology & Therapeutics|January 3, 2017
Letter: is body-mass index really associated with fibrosis regression during long-term nucleoside analogue therapy in chronic hepatitis B? Authors' replyW-K Seto, M-F Yuen
Heart (British Cardiac Society)|December 16, 2006
Atrial myxomaH H Ho, W K Seto, E Wang, et al.
BMJ Case Reports|June 21, 2011
Atrial myxomaH H Ho, W K Seto, E Wang, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 14, 2022
Reversibility of liver stiffness after tricuspid annuloplasty: a case-control study (abridged secondary publication)K H Yiu, W K Seto, M F Yuen, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|January 2, 2025
Regression of liver fibrosis after seroclearance of hepatitis B surface antigen: a prospective matched case-control study using transient elastography and serum Enhanced Liver Fibrosis test (abridged secondary publication)L Y Mak, M F Yuen, W K Seto, et al.
Journal of Viral Hepatitis|July 28, 2010
Prognostic significance of liver stiffness for hepatocellular carcinoma and mortality in HBeAg-negative chronic hepatitis BJ Fung, C-L Lai, W-K Seto, et al.
Journal of Viral Hepatitis|February 11, 2017
Relationship between HBsAg, HBcrAg and hepatocellular carcinoma in patients with undetectable HBV DNA under nucleos(t)ide therapyK-S Cheung, W-K Seto, D K-H Wong, et al.
Journal of Viral Hepatitis|June 23, 2011
Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year follow-up studyJ Fung, C L Lai, D K H Wong, et al.
Alimentary Pharmacology & Therapeutics|January 24, 2018
Review article: long-term safety of oral anti-viral treatment for chronic hepatitis BG L-H Wong, W-K Seto, V W-S Wong, et al.
Alimentary Pharmacology & Therapeutics|October 17, 2017
Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infectionL-Y Mak, D K-H Wong, K-S Cheung, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Alimentary Pharmacology & Therapeutics|January 3, 2017
Letter: is body-mass index really associated with fibrosis regression during long-term nucleoside analogue therapy in chronic hepatitis B? Authors' replyW-K Seto, M-F Yuen
Heart (British Cardiac Society)|December 16, 2006
Atrial myxomaH H Ho, W K Seto, E Wang, et al.
BMJ Case Reports|June 21, 2011
Atrial myxomaH H Ho, W K Seto, E Wang, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 14, 2022
Reversibility of liver stiffness after tricuspid annuloplasty: a case-control study (abridged secondary publication)K H Yiu, W K Seto, M F Yuen, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|January 2, 2025
Regression of liver fibrosis after seroclearance of hepatitis B surface antigen: a prospective matched case-control study using transient elastography and serum Enhanced Liver Fibrosis test (abridged secondary publication)L Y Mak, M F Yuen, W K Seto, et al.
Journal of Viral Hepatitis|July 28, 2010
Prognostic significance of liver stiffness for hepatocellular carcinoma and mortality in HBeAg-negative chronic hepatitis BJ Fung, C-L Lai, W-K Seto, et al.
Journal of Viral Hepatitis|February 11, 2017
Relationship between HBsAg, HBcrAg and hepatocellular carcinoma in patients with undetectable HBV DNA under nucleos(t)ide therapyK-S Cheung, W-K Seto, D K-H Wong, et al.
Journal of Viral Hepatitis|June 23, 2011
Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year follow-up studyJ Fung, C L Lai, D K H Wong, et al.
Alimentary Pharmacology & Therapeutics|January 24, 2018
Review article: long-term safety of oral anti-viral treatment for chronic hepatitis BG L-H Wong, W-K Seto, V W-S Wong, et al.
Alimentary Pharmacology & Therapeutics|October 17, 2017
Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infectionL-Y Mak, D K-H Wong, K-S Cheung, et al.
Pageof 2